首页> 外国专利> METHOD FOR PREDICTING TREATMENT EFFICACY OF PEGINTERFERON PLUS RIBAVIRIN TREATMENT IN A SUBJECT SUFFERING FROM HEPATITIS C

METHOD FOR PREDICTING TREATMENT EFFICACY OF PEGINTERFERON PLUS RIBAVIRIN TREATMENT IN A SUBJECT SUFFERING FROM HEPATITIS C

机译:预测丙型肝炎病毒感染受试者中PEG干扰素加利巴韦林治疗效果的方法

摘要

The present invention provides a method for predicting treatment efficacy of peginterferon plus ribavirin treatment in a subject suffering from chronic hepatitis C comprising: (a) measuring gene expression levels of genes comprising RSAD2, LOC26010, HERC5, HERC6, IFI44, SERPING1, IFITM3 and DDX60 of a blood sample from the subject after one week of the peginterferon plus ribavirin treatment; and (b) calculating a gene score according to cumulative fold change of the gene expression levels, when the gene score is equal to or higher than a cut-off value, the method predicts successful treatment of chronic hepatitis C with the peginterferon plus ribavirin treatment for the subject.
机译:本发明提供了在患有慢性丙型肝炎的受试者中预测聚乙二醇干扰素加利巴韦林治疗的疗效的方法,其包括:(a)测量包含RSAD2,LOC26010,HERC5,HERC6,IFI44,SERPING1,IFITM3和DDX60的基因的基因表达水平。接受聚乙二醇干扰素加利巴韦林治疗一周后,从受试者的血液样本中提取; (b)根据基因表达水平的累积倍数变化计算基因得分,当该基因得分等于或高于临界值时,该方法预测聚乙二醇干扰素联合利巴韦林治疗成功治疗慢性丙型肝炎为主题。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号